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Abstract Mammalian ovarian follicular development is
tightly regulated by crosstalk between cell death and sur-
vival signals, which include both endocrine and intra-
ovarian regulators. Whether the follicle ultimately ovulates
or undergoes atresia is dependent on the expression and
actions of factors promoting follicular cell proliferation,
differentiation or apoptosis. Prohibitin (PHB) is a highly
conserved, ubiquitous protein that is abundantly expressed
in granulosa cells (GCs) and associated with GC differ-
entiation and apoptosis. The current study was designed to
characterize the regulation of anti-apoptotic and pro-
apoptotic factors in undifferentiated rat GCs (gonadotropin
independent phase) governed by PHB. Microarray tech-
nology was initially employed to identify potential apop-
tosis-related genes, whose expression levels within GCs
were altered by either staurosporine (STS) alone or STS in
presence of ectopically over-expressed PHB. Next,
immunoblot studies were performed to examine the
expression patterns of selective Bcl-2 family members
identified by the microarray analysis, which are commonly
regulated in the intrinsic-apoptotic pathway. These stud-
ies were designed to measure protein levels of Bcl2 family
in relation to expression of the acidic isoform
(phosphorylated) PHB and the components of MEK-Erk1/2
pathway. These studies indicated that over-expression of
PHB in undifferentiated GCs inhibit apoptosis which con-
comitantly results in an increased level of the anti-apoptotic
proteins Bcl2 and Bclxl, reduced release of cytochrome c
from mitochondria and inhibition of caspase-3 activity. In
contrast, silencing of PHB expression resulted in change of
mitochondrial morphology from the regular reticular net-
work to a fragmented form, which enhanced sensitization of
these GCs to the induction of apoptosis. Collectively, these
studies have provided new insights on the PHB-mediated
anti-apoptotic mechanism, which occurs in undifferentiated
GCs through a PHB ? Mek-Erk1/2 ? Bcl/Bcl-xL path-
way and may have important clinical implications.
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Introduction
Apoptosis is a genetically controlled cellular suicide
mechanism that plays a crucial role in the development and
defense of homeostasis in each organ system. In the ovary,
more than 99 % of follicles disappear, primarily due to
apoptosis of granulosa cells (GCs) during follicular growth
and development [1, 2]. Ovarian GCs play an important
physiological role in supporting the development and
selection of the ovarian follicle by controlling oocyte
maturation and by producing the steroid hormones, estra-
diol and progesterone, that are critical for maintenance of
the ovarian cycle. Both biochemical and morphological
characteristics of apoptosis have been observed in the GCs
of atretic follicles [3–5]. However, the mechanism by
which GCs escape apoptosis during gonadotrophin
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independent phase is poorly understood. For these reasons,
analyses of the molecular events occurring during gonad-
otrophin independent phase development of GC are pivotal
to our understanding of how these cells contribute to the
modulation of processes critical for oocyte development.
To date, many apoptosis-related factors have been impli-
cated in follicular atresia, including death ligands and
receptors, intracellular pro- and anti-apoptotic molecules,
cytokines and growth factors that regulate functionally
distinct phases (initiation, effector and degradation) of
apoptosis. During the initiation phase of apoptosis, cells
receive death inducing signals from MEK to ERK pathway
which are executed by degradation of specific target pro-
teins and inter-nucleosomal/chromosomal DNA [6, 7].
Currently, our knowledge of transcriptional and transla-
tional cascades involved in survival signaling during fol-
liculogenesis remains incomplete. Studies from our
laboratory have shown that prohibitin (PHB) is one of the
survival factors in undifferentiated rat GCs [8–10].
Prohibitins [PHB (prohibitin, b cell associated protein
32) and repressor of estrogen receptor activity (REA,
prohibitin PHB2, b-cell associated protein 37)] are highly
conserved protein families that are thought to play specific
roles in cell cycle control, differentiation, senescence and
antiproliferative activity [10]. A growing body of evidence
has implicated a role for PHB in mitochondrial structure,
function and inheritance [8–14]. Previously published
experimental observations [8, 9] suggested that PHB may
be a cell survival or anti-apoptotic factor that is likely to
play an important role in cell fate decision and in mito-
chondrial integrity/cellular homeostasis. However, details
about the anti-apoptotic mechanisms involving PHB at the
transcriptional and translational level in undifferentiated
GCs are still unclear.
In order to elucidate the anti-apoptotic mechanisms
mediated by PHB in GCs isolated from immature rat fol-
licles, the staurosporine (STS) induced apoptotic model
was analyzed using Affymetrix microarray technology.
This experimental strategy was utilized to identify potential
apoptosis-related genes, whose expression levels within the
undifferentiated GCs were altered by the PKC inhibitor,
STS alone or in presence of over-expressed PHB. STS at
higher (micro molar) concentration has been extensively
used in vitro as an initiator of apoptosis in many different
cell types [15, 16] including GCs in our previously pub-
lished studies [8], whereas at lower (nano molar) concen-
tration it is an inhibitor of PKC [15, 16]. Based on these
studies, induction of apoptosis in undifferentiated GCs was
achieved using 1 lM STS within the period of 4 h [8].
Using this model of STS induced apoptosis in undifferen-
tiated GCs microarray studies identified several members
of the Bcl2 family. Immunoblot studies were then per-
formed to analyze the expression levels of selective Bcl-2
family members, which are commonly regulated in the
intrinsic-apoptotic pathway at the protein level. Parallel
studies were performed to examine expression of the acidic
(phosphorylated) isoform of PHB and its relationship with
the MEK-Erk1/2 pathway. In addition, we also analyzed
the role of PHB in relation to STS induced mitochondrial
morphological changes.
Materials and methods
Granulosa cell (GC) cultures
Primary undifferentiated GCs were isolated from immature
(23 days old) Sprague–Dawley rat ovaries as previously
described [8]. Ovaries were collected into serum-free
medium (4F), which consists of 15 mM HEPES, pH 7.4,
Dulbecco’s modified Eagles’s medium/F-12 with transfer-
rin (5 lg/ml), human insulin (2 lg/ml), hydrocortisone
(40 ng/ml), and antibiotics. After incubating the ovaries at
37 C in 4F medium containing 0.5 M sucrose and 10 mM
EGTA for 30 min, the ovaries were washed in fresh 4F
medium. Undifferentiated GCs were collected from the
ovaries by puncturing follicles with a 25-gauge hypoder-
mic needle, and cells were dispensed into 4F medium
supplemented with 10 % FBS (GIBCO BRL, Grand Island,
NY, USA), and incubated in a humidified atmosphere of
5 % CO2 at 37 C. The GCs isolated from sexually
immature 23–25-day-old rats are referred to as undiffer-
entiated because they lack the presence of functional LH
receptor and do not produce estrogen or progesterone under
basal conditions. However, these cells respond to FSH with
respect to the production of cAMP and induction of LH
receptor activation of the estrogen and progesterone bio-
synthetic pathways [17]. All experimental protocols were
submitted to the Institutional Animal Care and Use com-
mittee and were in accordance with the guidelines of the
National Institutes of Health and the U.S. Department of
Agriculture. This committee approved all animal care
handling procedures described in the present study.
Generation of recombinant adenoviral plasmid vectors
The PHB gene was amplified by PCR using rat ovarian
cDNA template as described previously by Chowdhury
et al. [8, 9]. The plasmid in the bacteria was amplified and
purified using a plasmid maxiprep system (Qiagen,
Valencia, CA, USA). The complete adenovector was lin-
earized and used for transfection of Ad293 cells (human
embryonic kidney cell line), where viral particles were
further amplified, purified, and titered according to the
manufacturer instruction [8, 9, 18]. The empty adenovirus
(Ad) vector was used as a control.
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The shRNA cassettes that specifically targeted specific
motifs in the PHB sequence were designed through shRNA
Target Finder (GenScript, Scotch Plains, NJ, USA) as
described previously by Chowdhury et al. [8, 9].
Adenoviral (Ad) infection of granulosa cells (GCs)
The undifferentiated GCs were grown on 6-well culture
dish (*2 9 106 cells/well) in 4F media supplemented with
10 % FBS. Subsequently, medium was removed and cells
were washed twice with 4F (antibiotics-free) and infected
with or without adenoviral vectors (Ad-eGFP: adenovirus
with GFP or Ad-eGFP-PHB: adenovirus GFP with sense
cDNA PHB; Ad-scrambled: adenovirus with scrambled
sequence RNA; Ad-eGFP-shPHB: adenovirus with small
interfering RNA designed for knockdown of PHB) at a
multiplicity of infection (MOI) of 10 plaque-forming units
per cell (pfu/cell) (based on our previous studies 8, 9) with
occasional rocking. After 2 h of incubation, media was
replaced with fresh 4F media without FBS and incubated
for 24 h. Infected GCs showed 95–100 % GFP expressions
at 10 pfu/cell (data not shown). Twenty-four hours after
exposure to adenoviruses, the media was replaced with
fresh 4F media without FBS in the presence or absence of
MEK inhibitor (PD98059; 20 lM) for 1 h. The cells were
then treated with or without STS (1 lM) for 2 h. Total
RNA and proteins were isolated for the further analysis. All
the doses and time for viral infection were based on our
previous experiments [8, 9].
Induction of apoptosis
The induction of GCs apoptosis were done in serum-free
medium in the presence of STS at a dose of 1 lM con-
centration for 2 h. STS concentration and time response
were used based on our previous experiments [8]. Fol-
lowing STS treatment the percentage of apoptosis was
determined by nuclear staining with Hoechst 33248 stain
(12.5 ng/ml; Sigma) as described by Chowdhury et al. [8,
9]. At least 250–300 cells were counted for each data point.
Caspase enzyme activity
Caspase-3 activity was measured using a colorimetric assay
kit (CaspACE-colorimetric; Promega, Madison, WI, USA)
as described previously by Chowdhury et al. [8, 9]. Caspase-
3 activity was calculated in picomoles per hour per micro-
gram of protein and plotted as percentage of control.
Microarray sample preparation and hybridization
To analyze the differentially expressed mRNA profiles at
the end of each experiments, cells were washed with ice
cold PBS and stored at -70 C until RNA was prepared.
Total RNA was extracted with TRIzol Reagent (Life
Technologies, Rockville, MD, USA), purified (RNAqueous
Kit, Ambion, Austin, TX, USA) and converted to double-
stranded cDNA (Invitrogen, Superscript Choice System,
Carlsbad CA, USA) using a T7-(dT)24 primer. The double-
stranded cDNA was isolated using Phase Lock Gels
(Eppendorf, Westbury, NY, USA)–phenol/chloroform/iso-
amyl alcohol (Sigma, St. Louis, MO, USA). cRNA was
synthesized using a RNA transcript labeling kit (Enzo
Diagnostics, Farmingdale, NY, USA). Biotin-labeled cRNA
was purified using a GeneChip Sample Cleanup Module
(Affymetrix Inc, Santa Clara, CA, USA) and then quantified
using a spectrophotometer. Next, twenty micrograms
(20 lg) of the in vitro transcription product was fragmented
by placing at 94 C for 35 min in fragmentation Buffer.
Following fragmentation, 15 lg of the biotinylated cRNA
was hybridized to an Affymetrix Rat Genome U34A
GeneChip with 8799 probe sets (genes). The chips were
hybridized at 45 C for 16 h, and then washed, stained with
streptavidin–phycoerythrin, and scanned according to
guidelines provided by the manufacturer.
Microarray data processing
Data analysis was performed by Affymetrix Microarray
Suite (MAS) 5.0 software. The microarray suite references
the experimental file to select an analysis algorithm for a
cell intensity file that generates a gene chip file. Single
array analysis was used to build the databases of gene
expression profiles. Affymetrix GCOS software was used
to normalize and analyze the data. Detection P value (set at
P \ 0.05) was used to statistically determine whether a
transcript is expressed on the chip. The software generated
a present (P), marginal (M), or absent (A) call for each
transcript based on the P value. To obtain differentially
expressed genes for each condition, Affymetrix GeneChip
Operating Software (GCOS) was used to compare each of
the STS treated alone or in presence of Ad-eGFP or Ad-
eGFP-PHB arrays to that of the control arrays. Absolute
calls (P, M and A) and the average difference (RNA
abundance) for each gene were then imported into Gene-
spring software (Silicon Genetics, Redwood City, CA,
USA) for a self-organizing map (SOM) cluster analysis by
dividing the genes of control versus experimental clusters
based on the expression patterns. By combining the fold
change and the present calls derived from the comparisons,
we obtained a list of differentially expressed genes for each
condition. Differential expression was calculated as the
increase between the controls and STS treated groups (i.e.
control versus STS treated group, Ad-eGFP or Ad-eGFP-
PHB alone versus Ad-eGFP or Ad-eGFP-PHB with STS).
A gene was considered differentially expressed when the
Apoptosis (2013) 18:1513–1525 1515
123
standard deviation of the signal increase or decrease was
significantly smaller than the absolute change in average
difference and the calculated confidence level of a gene
was set greater than 95 % (P \ 0.05 based on unpaired
t test). The general view of the effect of the PHB on gene
expressions in the GCs were obtained by SOM cluster
analysis using Genespring software (Silicon Genetics) on
replicate samples. Selected clusters were examined for
biological function and pathway analysis using Affymetrix
Netfix Analysis Center (http://www.affymetrix.com). Net-
fix detailed and annotated individual probe sets based on
biological and molecular function or cellular localization
using the Gene Ontology public database.
Assessment of mitochondrial changes
For the assessment of mitochondrial integrity, GCs were
stained with 200 nm MitoTracker Red solution in 4F
medium at 37 C temperatures for 15 min as described
previously by Chowdhury et al. [8, 9], and were analyzed
using a laser scanning confocal microscope imaging sys-
tem (Olympus Corp., Melville, NY, USA).
Isolation of S-100 fraction and mitochondria
S-100 (cytosolic) fractions and mitochondria were prepared
as described by Chowdhury et al. [8, 9]. Protein expression
levels in the respective cellular fractions were analyzed by
Western blot.
Western blot analysis
GC protein extracts obtained from different treatment
conditions were subjected to one- or two-dimensional gel
electrophoresis. The procedures used for one- and two-
dimensional gel electrophoresis, protein transfer, and
blotting have been described previously [8, 9, 13]. For one-
dimensional gel electrophoresis, equal amounts of protein
(25 lg) were applied to each lane. For two-dimensional gel
electrophoresis, eighty micrograms of protein purified from
mitochondrial fractions isolated from cultured GCs after
treatment were focused in the first dimension on IPG pH
gradient 4–7 strips for 60 kV-h using a Bio-Rad Protean
IEF Cell and second dimension followed by the Western
blotting procedure and PHB antibody to detect protein
spots corresponding to PHB. Primary antibodies used were
rabbit polyclonal PHB (1:1,000; Neomarks, Fremont, CA,
USA), mouse monoclonal cleaved caspase 3 (1:1,000; Cell
Signaling, Beverly, MA, USA), mouse monoclonal cyto-
chrome c (1:1,000; Cell Signaling, Beverly, MA, USA),
rabbit polyclonal Bcl2 (1:1000; Cell Signaling, Beverly,
MA, USA), rabbit polyclonal Bclxl (1:1,000; Cell Signal-
ing, Beverly, MA, USA), rabbit polyclonal Bax (1:1,000;
Cell Signaling, Beverly, MA, USA), rabbit polyclonal Bak
(1:1,000; Cell Signaling, Beverly, MA, USA), rabbit
polyclonal total Erk1/2 and pErk1/2 (1:1,000; Cell Sig-
naling, Beverly, MA, USA), rabbit polyclonal porin
(1:1,000; Cell Signaling, Beverly, MA, USA) and cyclo-
philin-a (1:1,000; Neomarks, Fremont, CA, USA). Mem-
branes were incubated with the appropriate secondary
antibody for 2 h at room temperature, and antibody binding
was detected by chemiluminescence (Pierce, Rockford, IL,
USA). Results of representative chemiluminescence were
scanned and densitometrically analyzed using a Power
Machintosh Computer (G3; Apple Computer Inc., Cuper-
tino, CA, USA) equipped with a ScanJet 6100C Scanner
(Hewlett-Packard Co., Greeley, CO, USA). Quantification
of the scanned images was performed according to the NIH
Image version-1.61 software (National Institute of Health,
Bethesda, MD, USA).
Quantification of the pro-apoptotic Bcl2 protein
versus anti-apoptotic Bcl2 protein ratio
Quantitative analysis of the pro-apoptotic Bcl2 protein
versus anti-apoptotic Bcl2 protein expression were per-
formed using a scanning densitometer and Multianalyst
Software Version 1.0.2 (Biorad, Munich, Germany) as
described by Prokop et al. [19]. Standardization of protein
loading was achieved as follows: (1) protein measurements
of all samples were performed using the Bio-Rad Protein
assay kit and equal amounts of protein (25 lg per lane)
were loaded on the gel; (2) transfer efficiency of the
Western blots was routinely checked by staining the
membranes with 0.5 % Ponceau Red in 1 % acetic acid; (3)
for chemiluminescent detection, films were exposed for
exactly the same length of time, and were optimized for
each antibody used in this study; and (4) detection of Bax,
Bak, Bclxl and Bcl2 were performed separately using the
same membrane. This procedure facilitated quantitative
determination of the protein ratios in the same sample (on
the same lane of the gel). Values of protein expression are
given in arbitrary units in percentages after normalization
to cyclophilin A. Linearity of protein detection was
checked for Bcl2 family protein using standard cell extracts
as provided by the Cell Signaling, Beverly, MA.
Statistical analysis
All experiments were replicated a minimum of three times,
unless otherwise stated. Data are expressed as mean ±
SEM of three experiments. Statistical analysis was per-
formed by one-way ANOVA using SPSS version 11.0
software (SPSS, Chicago, IL, USA). Multiple comparisons
were done by Newman–Keuls’ test. Differences were
considered significant at P B 0.05.
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Results
Over expression of PHB inhibits apoptosis
in undifferentiated GCs
As shown in Fig. 1A, apoptotic cell death with STS was
potent and significant (P \ 0.05; Newman–Keuls’ test) in
rat primary GC culture system. STS treatment resulted in
cell detachment, loss of cell processes, membrane shrink-
age, as evidenced by curling of cells and formation of
apoptotic bodies. Staining (Hoechst 33248) of nucleus
showed significant (23–30 %, P \ 0.05; Newman–Keuls’
test) nuclear morphologic changes with chromatin con-
densation and fragmentation into apoptotic bodies after
STS treatment with or without Ad-eGFP infection of the
GCs (Fig. 1B). In marked contrast, less than 5 % Ad-
eGFP-PHB-infected cells were apoptotic compared to their
parallel control groups. Based on these results, we used
1 lM dose of STS treatment of GCs for 2 h for all other
experimental studies.
Caspase-3 has been shown to be a potent effector caspase
that targets several specific cellular proteins causing a
number of changes associated with cell death. Therefore, the
apoptotic nature of cell death was further verified by exam-
ining the biochemical differences observed in the Ad-eGFP
or Ad-eGFP-PHB infected cells in presence or absence of
STS by quantification of caspase-3-enzyme activity. Ana-
lysis of cytosolic caspase-3 enzymatic activities after STS
Fig. 1 Effects of recombinant adenovirus-directed overexpression of
PHB on PKC inhibitor, STS induced apoptosis in undifferentiated rat
GCs. Undifferentiated GCs were infected with sense adenovirus-
eGFP-PHB (MOI = 10) or an adenovirus-eGFP vector control
(MOI = 10) for 2 h and maintained in culture for 24 h along with
uninfected parallel control groups. Thereafter, GCs were treated with
STS (1 lM) for 2 h. A Live cell photographs were taken under an
inverted epifluorescence microscope at 9400 magnification showing
green fluorescence for the overexpressed eGFP-PHB or eGFP alone
along with phase contrast pictures at 2 h in presence or absence of
STS. B Data shown represent the percentage of cells displaying
nuclear morphologic changes characteristic of apoptosis. C Data
representing the caspase 3 activity as % of control groups in cytosolic
protein extracts from GCs after completion of treatments measured
using the spectrophotometric substrate DEVD-pNA(D). D cDNA
Microarray analysis profile of total mRNA of STS induced changes in
presence or absence of recombinant adenovirus-directed over-
expressed PHB in undifferentiated GCs. Data is represented by as a
scatter plot of the expression of all the genes (8799) present on
Affymetrix Rat Genome (RGU34A) Gene Chip showing expression
twofold or more following STS treatment in presence or absence of
PHB. Fold change lines represent genes that increase or decrease in
signal intensity by twofold or more. E cDNA Microarray analysis of
apoptotic genes expression that increased significantly with STS
treatment and decreased significantly with in presence of PHB (see
Table 1). Significance based on twofold change increase or decrease.
All numerical values are represented as mean ± SEM of three
individual experiments (n = 3). The values show overall significance
in one way ANOVA test (P \ 0.001). All groups are significantly
different (P \ 0.05, Newman–Keuls’ test) except the groups indi-
cated by a and b
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treatment for 2 h showed a significant (P B 0.05) increase
(three to fourfold) in caspase-3 activity in GCs infected with
empty Ad-vector (Ad-eGFP) compared to Ad-eGFP-PHB
infected group (Fig. 1C). In agreement with the morpho-
logical differences observed and quantitative measures of the
extent of apoptosis in the undifferentiated GCs, these studies
suggest that exogenous over-expression of PHB provides
marked inhibition against STS-induced apoptosis.
Over expression of PHB increases the levels
of expression of anti-apoptotic Bcl2 family members
in undifferentiated GCs
To explore the mechanism through which PHB is able to
prevent apoptosis in undifferentiated GCs treated with STS
to activate the intrinsic apoptotic pathway, the microarray
experiments were used to generate a unbiased global view
of gene expression patterns in the respective experimental
samples (Fig. 1D). To assess inter-experimental differ-
ences in intensity of gene expressions, replicate experi-
ments were compared for each experimental group. To
elucidate the magnitude of the changes in gene expression
and the functional significance of PHB in STS-induced
gene regulation in the undifferentiated GCs, we subjected
the genes from the three SOM clusters (each control to the
STS samples and STS to STS ? PHB samples) to pathway
analysis using the Affymetrix web based program NetAffx
[20]. Using NetAffx, we examined genes with annotations
related to biological processes. The genes regulated during
STS and STS with PHB treatment fell into several broad
categories including development, morphological, cell
growth and maintenance, signal transduction, metabolism,
transport and apoptosis. Treatment of the GCs with Ad-
eGFP-PHB resulted in a reduction in the expression levels
of many of the apoptotic inducing genes by 50 % or more.
Therefore, we restricted our analysis to apoptotic related
gene products (Fig. 1E). Based on the apoptotic gene
cluster analysis, genes were selected that showed *1.5 to
twofold difference on each individual probe set. The
selected gene names and the GenBank accession numbers
are included in Table 1 and their expression profiles under
the experimental conditions are shown in Fig. 1E. A large
proportion of these apoptotic genes appeared to be asso-
ciated with the Bcl family. Interestingly, a number of major
pro-apoptotic regulators including Bax and Bak were also
specifically regulated upon STS treatment with almost
identical expression profiles. After initial induction with
Ad-eGFP-PHB for 24 h, both Bax and Bak are down-
regulated. Furthermore, caspase-3 gene expression that was
specifically activated upon STS treatment was down-reg-
ulated in the Ad-eGFP-PHB treated groups. Compared to
pro-apoptotic regulators, two major anti-apoptotic gene
transcripts Bcl2 and Bclxl were up-regulated in GCs
infected with Ad-eGFP-PHB and treated with or without
STS.
Based on the gene array analyses, we selected eight
candidate genes and tested their influence on cell death
versus cell survival mechanisms. First, we explored whe-
ther over-expression of PHB prevented apoptosis at the
mitochondrial level by inhibiting mitochondrial cyto-
chrome c release to cytosol and concomitant activation of
down-stream caspase-3, as part of the anti-apoptotic
mechanism. As shown in Fig. 2A, a majority of cyto-
chrome c was released from mitochondria to the cytosol in
control/or Ad-eGFP infected GCs treated with STS. In
contrast, only a small amount of cytochrome c was released
from mitochondria to cytosol in Ad-eGFP-PHB infected
cells treated with STS for 2 h. Similar to the differential
release of mitochondrial cytochrome c to cytosol in dif-
ferent treated groups, the activation of caspases-3 also
showed a differential pattern with positive relationship to
cytosolic cytochrome c release. STS treatment of control/or
Ad-eGFP infected cells revealed more than three to four-
fold higher activation of caspases-3 expression compared
to untreated controls or Ad-eGFP-PHB infected GCs. Thus,
over-expression of PHB was able to block downstream
apoptotic events through inhibiting the release of cyto-
chrome c. Next, we examined the relative expression levels
of pro- and anti-apoptotic Bcl family proteins including
Bcl2, Bclxl, Bax and Bak. The expression of Bcl2, Bcl-xl,
Bax and Bak showed significant variations in control and
Ad-eGFP/Ad-eGFP-PHB infected groups with or without
STS treatment (Fig. 2A). Interestingly, an enhanced level
of Bcl2 and Bclxl protein expression was revealed in Ad-
eGFP-PHB infected cells. Moreover, in the Ad-eGFP-PHB
infected cells, Bax and Bak expression were suppressed
even in presence of STS. The quantitative expression
analysis represented by Bax/Bcl2, Bax/Bclxl, Bak/Bcl2
and Bak/Bclxl ratios are shown in Fig. 2B. In confirmation
of our initial observations, we found that Bax/Bcl2, Bax/
Table 1 Microarray analysis of gene expression patterns in rat
undifferentiated granulosa cells stimulated by PKC inhibitor, STS in
presence and absence of adenovirus directed over-expressed prohib-
itin-1 (Ad-eGFP-PHB1)
Accession number Name STS STS ? Ad-
eGFP-PHB1
NM_031851.2 Prohibitin-1 2.33 4.93
AF155236.1 ERK1b 1.38 2.11
NM_012840.1 Cyt C 19.63 9.32
NM_012922.2 Caspase-3 2.62 1.35
NM_016993.1 Bcl2 1.05 2.24
NM_001033670 BclXL 1.35 2.35
NM_017059.1 Bax 1.57 0.57
AF259504 Bak 1.48 0.74
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Bclxl, Bak/Bcl2 and Bak/Bclxl ratios were significantly
two to threefolds lower in Ad-eGFP-PHB infected GCs. In
addition, we also analyzed the expression levels of total
and phosphorylated Erk, since the Erk pathway genes were
also found to be regulated by gene-array analysis. In Ad-
eGFP-PHB infected cells, we also observed enhanced
expression of pErk compared to parallel control or Ad-
eGFP infected cells or treated with STS (Fig. 2A). These
results suggest that over-expression of PHB may, at least in
part, exert its protective effects by suppressing STS-
induced apoptotic gene expression (Bax and Bak) and
enhancing expressions of the anti-apoptotic proteins (pErk,
Bcl2 and Bclxl) in GCs.
Over expression of PHB activates expression of anti-
apoptotic factors through phosphorylated Erk (pERK)
in undifferentiated GCs
We explored whether over-expression of PHB inhibited
apoptosis through activation of the MEK-Erk-signaling
pathway. As shown in Fig. 3A, B, apoptotic cell death and
caspase-3 activity were most potent and significant
(P \ 0.05; Newman–Keuls’ test) in presence of the MEK-
inhibitor (PD98059) in STS treated GCs. The MEK-
inhibitor in presence of STS also significantly (P \ 0.05;
Newman–Keuls’ test) promoted cell death and enhanced
caspases-3 activity in over-expressed PHB GCs when
Fig. 2 Western blot analysis of recombinant adenovirus-directed
over-expression of PHB on PKC inhibitor, STS induced apoptosis
related change in protein profile in undifferentiated rat GCs.
Undifferentiated GCs were infected with sense adenovirus-eGFP-
PHB (MOI = 10) or an adenovirus-eGFP vector control (MOI = 10)
for 2 h and maintained in culture for 24 h along with uninfected
parallel control groups. Thereafter, GCs were treated with STS
(1 lM) for 2 h. A Representative Western blots of protein levels in
GCs treated by STS in presence and absence of adenovirus directed
over-expressed PHB for PHB, cleaved caspase 3, cytochrome c
(mitochondrial and cytosolic), Bcl2, Bclxl, Bax, Bak, total Erk1/2 and
pErk1/2. Porin and cyclophilin A were used as internal controls for
mitochondria and cytosol, respectively. Data is representative of three
individual experiments (n = 3) that were performed for each
individual group. B The bar graphs representing the % mean ± SEM
of Bax/Bclxl, Bax/Bcl2, Bak/Bclxl and Bak/Bcl2 ratios of protein
levels normalized by cyclophilin A. Data are representative of three
individual experiments (n = 3) that were performed for each
individual group. The values show overall significance as indicated
in one way ANOVA test (P \ 0.001). All groups were significantly
different (P \ 0.05, Newman–Keuls’ test) except the groups indi-
cated by a–c
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compared to the parallel control GCs without MEK
inhibitor (Fig. 3A, B). Interestingly, in GCs, pretreatment
of MEK-inhibitor (PD98059) at 20 lM for an hour did not
elicit any cell death (Table 2). Our unpublished results also
shown that GCs were treated with PD98059 for 4 h did not
increase in cell death [21].
We further analyzed whether mitochondrial PHB coor-
dinates the signaling between MEK1 and ERK1/2 by
1520 Apoptosis (2013) 18:1513–1525
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affecting MEK1 activation in response to STS treatment in
primary GCs and whether it affects Bcl family members.
As shown in Fig. 3C, 2-D Western blot analysis, revealed
that mitochondrial PHB is phosphorylated [8, 10] when the
undifferentiated GCs were treated with STS, whereas the
phosphorylated form of mitochondrial PHB was inhibited
by the MEK inhibitor (PD98059). Next, we analyzed the
relative expression levels of pro- and anti-apoptotic Bcl
family proteins (Bcl-2, Bclxl, Bax and Bak) under these
experimental conditions. The expression levels of Bcl2,
Bclxl, Bax and Bak showed significant variations in Ad-
eGFP infected cells when compared to Ad-eGFP-PHB
infected groups with or without STS treatment in presence
or absence of MEK-inhibitor (Fig. 3D). In presence of
MEK inhibitor, Ad-eGFP-PHB infected GCs treated with
STS showed a marked decreased in Bcl-2 and Bcl-XL
protein content and enhanced levels of expressions of Bax
and Bak. The quantitative analysis of Bax/Bcl-2, Bax/Bcl-
XL, Bak/Bcl2 and Bak/Bclxl ratios revealed significant
(P \ 0.05; Newman–Keuls’ test) two to threefold lower
protein ratios in Ad-eGFP-PHB infected GCs in presence
of MEK inhibitor and STS treatment. These observations
correlated with our data on cytochrome c released from
mitochondria to the cytosol in the STS treated GCs in
presence or absence of MEK inhibitor. In presence of MEK
inhibitor, the STS treated undifferentiated GCs are more
sensitized even in Ad-eGFP-PHB treated undifferentiated
GCs and released high amounts of cytochrome c from
mitochondria to cytosol. Moreover, in presence of MEK
inhibitor, the activation of caspases-3 is significantly
(P \ 0.05; Newman–Keuls’ test) higher in STS treated
undifferentiated GCs, and this caspase-3 activity is directly
correlated with the release of cytosolic cytochrome c in
agreement with our previous studies [8, 9].
Knockdown of PHB induces mitochondrial
fragmentation and sensitizes undifferentiated GCs
to apoptosis
To study the effects of PHB on mitochondrial morphology
and its protective role against apoptosis, we knocked down
PHB gene expression in undifferentiated GCs using aden-
oviral shRNA (AdshRNA) (Fig. 4A). Infection with empty
Ad-vector alone did not show any changes in PHB levels.
As shown in Fig. 4B, shRNA-mediated (AdshRNA)
knock-down of PHB sensitized the GCs to STS treatment.
In presence of MEK inhibitor (PD98059), the GCs were
more sensitized and showed enhanced apoptosis compared
to AdshRNA scrambled infected cells (P \ 0.05; New-
man–Keuls’ test). Knock-down of PHB in presence of
MEK inhibitor in GCs treated with STS showed increased
caspases-3 activity of two to three fold compared to Ads-
hRNA virus infected cells (P \ 0.05; Newman–Keuls’
test) (Fig. 4C). These results, in part, suggest that MEK is
likely to be an important factor regulating apoptosis in
these undifferentiated GCs.
To further analyze the effects of PHB on mitochondrial
morphology in STS treated GCs, we studied the conse-
quences of knockdown of PHB in presence or absence of
STS on mitochondrial morphology by immunofluorescence
microscopy. As shown in Fig. 4D, AdshRNA infected
undifferentiated GCs have elongated and branch network
of mitochondria compared to AdshPHB infected GCs.
Interestingly, when AdshPHB infected undifferentiated
GCs were treated with STS, the mitochondrial reticulate
network were more sensitized and fragmented and








Control 0 0 ± 0 100 ± 0
PD98059 0 0 ± 0 100 ± 0
Control 1 0 ± 0 100 ± 0
PD98059 1 0 ± 0 100 ± 0
Control 2 0 ± 0 100 ± 0
PD98059 2 2 ± 1.15 103 ± 1.53
Control 3 0 ± 0 100 ± 0
PD98059 3 2.33 ± 1.2 103.67 ± 1.2
Fig. 3 Western blot analysis of recombinant adenovirus-directed
over-expression of PHB in presence or absence of MEK inhibitor
(PD98059) on the PKC inhibitor STS induced apoptosis in undiffer-
entiated rat GCs. Undifferentiated GCs were infected with sense
adenovirus-eGFP-PHB (MOI = 10) or an adenovirus-eGFP vector
control (MOI = 10) for 2 h and maintained in culture for 24 h
followed by treated with MEK inhibitor (PD98059) for 1 h.
Thereafter, undifferentiated GCs were treated with STS (1 lM) for
2 h in serum free media. a Data shown represent the percentage of
cells displaying morphological alteration of apoptosis based on
quantification of nuclear morphologic changes. b Graphically, data
represent the caspase 3 activity as % of control groups in cytosolic
protein extracts prepared from GCs after completion of treatments
and measured using the spectrophotometric substrate DEVD-pNA(D).
c 2D-Western blot analyses of mitochondrial protein levels for PHB
in undifferentiated GCs after various treatments as indicated.
d Representative Western blots of protein expression levels for
PHB, cleaved caspase 3, cytochrome c (mitochondrial and cytosolic),
Bcl2, Bclxl, Bax, Bak, total Erk1/2 and phosphor ERK1/2 (pErk1/2)
for the various treatment groups. Porin and cyclophilin A were used
as an internal control for mitochondria and cytosol, respectively.
e The bar graphs shown represent the % mean ± SEM of Bax/Bclxl,
Bax/Bcl2, Bak/Bclxl and Bak/Bcl2 ratios of protein levels normalized
to cyclophilin A from three replicate experiments. Data shown are a
representative of three individual experiments (n = 3) were per-
formed for each individual group. All numerical values are
represented as mean ± SEM of three individual experiments
(n = 3). The values shown indicate an overall significance as
determined by the one way ANOVA test (P \ 0.001). All groups
are significantly different (P \ 0.05, Newman–Keuls’ test)
b
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appeared as a punctuated form compared to STS treated
AdshRNA infected GCs.
Discussion
This current study demonstrates that PHB plays an anti-
apoptotic role in the mitochondrial intrinsic apoptotic
pathway and regulates expression of the Bcl family pro-
teins in STS induced apoptotic model of rat ovarian
undifferentiated GCs. Moreover, adenoviral directed
overexpression of PHB abrogated STS induced cytochrome
c release and subsequent activation of caspase 3, thereby
preserving the viability of these GCs by tilting the balance
in favor of survival. In contrast, shRNA mediated knock-
down of PHB using recombinant adenoviral vectors appear
to tilt the balance in favor of cell death by affecting the
integrity of mitochondrial architecture. Our results further
demonstrated that in the mitochondria, phosphorylated
PHB prevents expression of two major proapototic factors
Bax and Bak through the MEK-Erk-Bcl2/Bclxl pathway in
STS induced apoptosis in the undifferentiated GCs. Under
these experimental conditions increased expression of anti-
apoptotic factor Bcl2 and Bclxl were able to maintain the
integrity of the mitochondria architecture. The preservation
of cell viability in response to PHB over-expressions is
associated with enhanced translocation of PHB into the
mitochondria in response to STS induced apoptotic signals
[8, 9].
Apoptosis occurs through two major signaling path-
ways: extrinsic or intrinsic. The intrinsic apoptotic signal-
ing pathway which involves mitochondria results in the
release of pro-apoptotic factors from mitochondria, such as
cytochrome c. The released cytochrome c binds to the
apoptotic protease-activating factor-1(Apaf-1), and subse-
quently turns on downstream executioner caspases such as
Fig. 4 Western blot and morphological analysis of recombinant
adenovirus-directed silencing the PHB in presence or absence of
MEK inhibitor (PD98059) on PKC inhibitor, STS induced apoptosis
in undifferentiated rat GCs. Undifferentiated GCs were transiently
infected with AdshPHB (MOI 10) or Ad-scrambled (MOI 10) for 2 h
and maintained in culture for 48 h in serum free media followed by
treatment with or without MEK inhibitor (PD98059). Thereafter, the
GCs were treated with STS (1 lM) for 2 h in serum free media.
A Representative Western blots of protein expression levels for PHB
and cyclophilin A (as an internal control). B Data shown represent the
percentage of cells displaying morphological alteration of apoptosis
based on quantification of nuclear morphologic changes. C Data
shown represent the caspase 3 activity as % of control groups in
cytosolic protein extracts prepared from GCs after completion of
treatments and measured using the spectrophotometric substrate
DEVD-pNA(D). D Representative mitochondrial morphology
observed in STS treated or untreated GCs in presence of Ad-
scrambled or AdshPHB. White arrows indicate fragmented mito-
chondria. Representative microscopic analysis from three individual
experiments (n = 3) that were performed for each individual group.
All numerical values are represented as mean ± SEM of three
individual experiments (n = 3). The values show are overall signif-
icance determined by one way ANOVA test (P \ 0.001). All groups
are significantly different (P \ 0.05, Newman–Keuls’ test)
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caspase-3 [6, 7]. The anti-apoptotic and pro-apoptotic
members of the different protein families play a critical
role in STS induced apoptosis. Consistent with our previ-
ous studies, experimental data from the present study
shows that PHB regulates both anti-apoptotic and pro-
apoptotic members in STS induced apoptosis in undiffer-
entiated GCs. STS treatment was found to up-regulate both
mRNA and proteins of pro-apoptotic factors (Bax and Bak)
greater than two fold with up-regulation of cytochrome-c
release from mitochondria and increase caspases-3 activity
in STS treated control or Ad-eGFP infected GCs. Inter-
estingly, we did not observed any significant up-/down-
regulation of other key regulatory factors such as IAP, Bid,
Bad at the messenger levels under these experimental
conditions.
The analysis of proteins regulating mitochondrial func-
tions showed a strong correlation between the ratio of
members of the Bcl-2 protein family, including Bax, Bak,
Bclxl and Bcl-2, which determine the sensitivity of the
GCs to STS-mediated apoptosis. In our undifferentiated
GCs experimental model system, Bax/Bcl2, Bax/Bclxl,
Bak/Bcl2 and Bak/Bclxl ratios of less than 70 % were
characteristic for resistance to STS mediated apoptosis,
whereas, Bax/Bcl2, Bax/Bclxl, Bak/Bcl2 and Bak/Bclxl
ratios greater than 90 % were characteristic for the
increased sensitivity of the GCs to STS. The apoptosis
inhibiting effect of Bcl2 and Bclxl are counteracted by the
pro-apoptotic proteins Bax and Bak. Imbalance of the Bax
and Bak versus Bcl2 and Bclxl ratios tilts the scales toward
cell death and sensitized cells to a wide variety of cell
death stimuli, including all chemotherapeutic drugs, radi-
ation, hypoxia, or growth factor withdrawal and enhance
the resistance of cells to the cytotoxic effects [22–27].
Previous studies have demonstrated that ectopic Bcl2 over-
expression in sensitive cell lines prevented the triggering of
apoptotic stimuli, thereby supporting the role of the Bax/
Bcl-2 rheostat as a key checkpoint [27, 28]. The broad
resistance to cell death, occurring upon the intracellular
balance of the Bax/Bcl2, Bax/Bclxl, Bak/Bcl2 and Bak/
Bclxl ratios, have potential relevance for cell behavior
including cell invasion, adhesion, or metastatic potential
[29].
In agreement with these published observations, the
current experimental data in this study have further dem-
onstrated that PHB is also required for the phosphorylation
of ERK which is involved in induction of the anti-apoptotic
Bcl-2 factor. STS mediated phosphorylation of ERK1/2 is
dependent on PHB protein expression and PHB is also
required for MEK1 activity, suggesting that a possible
novel regulatory loop affecting this pathway is mediated by
PHB. Published studies have indicated that PHB plays an
important role in the Ras-mediated activation of the Raf/
MEK/ERK pathway [30, 31], which is a highly conserved
signaling cascade that regulates a multitude of essential
cellular functions such as proliferation and differentiation
[31]. Interestingly, we also observed that STS induced
phosphorylation of ERK suggesting an adaptive response
to cellular stress, which is newly observed phenomenon
that also occurs in undifferentiated GCs [32].
We detected a remarkable increment of the mitochon-
drial content of PHB in the STS treated undifferentiated
GCs when compared to PHB knock down group. In the
mitochondrial fraction, the concentration of PHB is much
higher in STS treated GCs, suggesting that the increase of
mitochondrial PHB is essential for stabilizing the mito-
chondrial integrity and maintaining mitochondrial mem-
brane potential in theses rat ovarian undifferentiated GCs
[8, 9, 33]. Mitochondria are dynamic structures that fuse
and divide continuously to adjust the shape and distribution
of the mitochondrial network which depends on cells state,
stage and energy demands, and therefore, plays critical
roles in cell physiology. The mitochondrial network is
composed of highly interconnected tubules formed by
balanced fusion and fission events [34]. Our immunofluo-
rescence study revealed that a transition of mitochondrial
morphology occurs from a reticular network to vesicular
punctiform or fragmentation following knockdown of PHB
with STS treatment. A decrease in the mitochondrial
reticular network connectivity is an early apoptotic signal
[35], that was also demonstrated in PHB-deficient MEFs
and PHB- or PHB2-silenced cells [36, 37]. These collective
observations suggest that PHB is an essential mitochondrial
protein that is involved in maintaining mitochondrial
integrity by promoting the fusion of mitochondrial mem-
branes. The mechanism(s) involved in participation of PHB
in the mitochondrial fusion/fission during the mitochon-
drial fragmentation leading to apoptosis may be explained
by altered processing of OPA1 [38; our unpublished study].
OPA1 is a large dynamin-like GTPase that is found in the
mitochondrial intermembrane space and regulates both
mitochondrial fusion and cristae morphogenesis [35]. Thus,
the reduced PHB content in mitochondria that occurs in
PHB knock down in undifferentiated GCs may be one of
the mechanisms to explain why changes in expression of
PHB affects mitochondrial integrity and membrane
potential in these cells [8, 9, 38, 39]. However, the detailed
mechanism by which PHBs affect OPA1 processing still
remains to be determined.
Thus, upon induction of apoptosis by STS, mitochon-
drial PHB through pPHB mediate activation of pERK
expression cascade that results in enhancement of the Bcl/
Bcl-xL pathway and inhibition of Bax-Bak, which directly
inhibits the release of cytochrome c from the inter-mito-
chondrial space resulting in inhibition of the downstream
activation of cleaved caspase 3. An alternative mechanism
leading to inhibition of apoptosis after mitochondrial PHB
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over-expression may, in part, be due to the prevention of
cytochrome c translocation into the cytosol thus protecting
the mitochondria from undergoing functional incapacita-
tion. The increased expression and translocation of PHB in
the mitochondria in response to apoptotic signals and the
delayed response to apoptotic stimulus that was observed
in the current studies supports the role of PHB as an anti-
apoptotic agent [8, 9]. Furthermore, these studies suggest
that over-expression of PHB in GCs may inhibit the rate of
oocyte depletion observed in females prior to menopause
through the proposed pMEK-pERK-Bcl2/Bcl-xL signaling
mechanisms. Thus, PHB may act either as a sensor for
mitochondrial integrity and homeostasis and/or as a sur-
vival factor that paradoxically mediates GCs fate decisions
during cellular proliferation and differentiation by delaying
the activation of the apoptotic pathways, to support pre-
antral and early antral follicular development in the ovary.
These studies have demonstrated that the adenovirus sys-
tem utilized in this study are a useful tool for facilitating
future studies that are designed to decipher the molecular
mechanisms involved in PHB mediated regulation of dif-
ferentiation and proliferation in undifferentiated GCs.
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